The North Asian private equity giant cited rising demand for semiconductor products amid the AI boom for its decision to invest in FICT.

Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion. Founded in 1678, Tanabe ...

There’s one more number to remember: When Hillenbrand bought Milacron, that also included the Cimcool business, which makes ...

Mitsubishi UFJ Morgan Stanley Securities and BofA Securities are serving as financial advisors, and Morrison Foerster, Mori, Hamada & Matsumoto and Ropes & Gray are serving as legal advisors to Bain ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Hillenbrand sells majority stake in mechanical engineering company to Bain Capital / Net losses, weak order intake © 2001-2025 Plasteurope.com | Imprint | Privacy | Cookie settings ...

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Xiaomi's shares hit a new intraday high in Hong Kong as optimism grew over the earnings outlook for the Chinese consumer-electronics specialist this year. The South Korean internet giant posted ...

The computer firm’s hybrid and remote workers — including those based out of the Hopkinton and Franklin offices — are expected to return to the office for five days a week next month, according to a ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.